Vessella R - Search Results

1

The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.

Lucas JM, True L, Hawley S, Matsumura M, Morrissey C, Vessella R, Nelson PS. Lucas JM, et al. Among authors: vessella r. J Pathol. 2008 Jun;215(2):118-25. doi: 10.1002/path.2330. J Pathol. 2008. PMID: 18338334

2

Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases.

Akfirat C, Zhang X, Ventura A, Berel D, Colangelo ME, Miranti CK, Krajewska M, Reed JC, Higano CS, True LD, Vessella RL, Morrissey C, Knudsen BS. Akfirat C, et al. J Pathol. 2013 Jul;230(3):291-7. doi: 10.1002/path.4180. J Pathol. 2013. PMID: 23420560 Free PMC article.

3

A molecular correlate to the Gleason grading system for prostate adenocarcinoma.

True L, Coleman I, Hawley S, Huang CY, Gifford D, Coleman R, Beer TM, Gelmann E, Datta M, Mostaghel E, Knudsen B, Lange P, Vessella R, Lin D, Hood L, Nelson PS. True L, et al. Among authors: vessella r. Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10991-6. doi: 10.1073/pnas.0603678103. Epub 2006 Jul 7. Proc Natl Acad Sci U S A. 2006. PMID: 16829574 Free PMC article.

4

Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.

Lin B, Ferguson C, White JT, Wang S, Vessella R, True LD, Hood L, Nelson PS. Lin B, et al. Among authors: vessella r. Cancer Res. 1999 Sep 1;59(17):4180-4. Cancer Res. 1999. PMID: 10485450

5

Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity.

Roudier MP, True LD, Vessella RL, Higano CS. Roudier MP, et al. Among authors: vessella rl. J Clin Pathol. 2004 Mar;57(3):321-3. doi: 10.1136/jcp.2003.010207. J Clin Pathol. 2004. PMID: 14990610 Free PMC article.

6

Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone.

Roudier MP, True LD, Higano CS, Vesselle H, Ellis W, Lange P, Vessella RL. Roudier MP, et al. Hum Pathol. 2003 Jul;34(7):646-53. doi: 10.1016/s0046-8177(03)00190-4. Hum Pathol. 2003. PMID: 12874759

7

Metastases of prostate cancer express estrogen receptor-beta.

Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E. Lai JS, et al. Urology. 2004 Oct;64(4):814-20. doi: 10.1016/j.urology.2004.05.036. Urology. 2004. PMID: 15491740

8

Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer.

Black PC, Mize GJ, Karlin P, Greenberg DL, Hawley SJ, True LD, Vessella RL, Takayama TK. Black PC, et al. Prostate. 2007 May 15;67(7):743-56. doi: 10.1002/pros.20503. Prostate. 2007. PMID: 17373694

9

The role of tumor microenvironment in prostate cancer bone metastasis.

Morrissey C, Vessella RL. Morrissey C, et al. J Cell Biochem. 2007 Jul 1;101(4):873-86. doi: 10.1002/jcb.21214. J Cell Biochem. 2007. PMID: 17387734 Review.

10

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.

Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Nelson PS, Coleman R, Wang YC, Corey E, Lange PH, Higano CS, Vessella RL. Morrissey C, et al. Among authors: vessella rl. Clin Exp Metastasis. 2008;25(4):377-88. doi: 10.1007/s10585-007-9116-4. Epub 2007 Oct 31. Clin Exp Metastasis. 2008. PMID: 17972146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters